JNJ - Johnson & Johnson
收市後：
| 前收市價 | 154.54 |
| 開市 | 154.72 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 0.00 x 1000 |
| 今日波幅 | 154.09 - 157.31 |
| 52 週波幅 | 150.11 - 183.35 |
| 成交量 | |
| 平均成交量 | 7,272,822 |
| 市值 | 407.923B |
| Beta 值 (5 年，每月) | 0.53 |
| 市盈率 (最近 12 個月) | 32.36 |
| 每股盈利 (最近 12 個月) | 4.85 |
| 業績公佈日 | 2023年7月20日 |
| 遠期股息及收益率 | 4.76 (3.08%) |
| 除息日 | 2023年5月22日 |
| 1 年預測目標價 | 179.71 |
Insider MonkeyS&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Popularity
In this article, we will discuss the best dividend aristocrat stocks sorted by hedge fund popularity. You can skip our detailed analysis of dividend aristocrats and their past performance, and go directly to read S&P 500 Dividend Aristocrats List: Top 10 Among Hedge Funds. Dividend aristocrats are companies in the S&P 500 that have a […]
Insider Monkey14 Best Annual Dividend Stocks To Buy Now
In this article, we discuss 14 best annual dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Annual Dividend Stocks To Buy Now. Dividend stocks are garnering investors’ attention in 2023 as the stock market recovers from […]
BenzingaJohnson & Johnson Back in Court Over Talc-Related Cancer Claims
Yesterday, Johnson & Johnson (NYSE: JNJ) faced the trial related to the lawsuit accusing its baby powder and other talc products of causing cancer. This is the first trial in almost two years related to the suit, with the company seeking to settle thousands of similar cases in bankruptcy court, Reuters reported. Emory Hernandez, aged 24, claims to have developed deadly cancer, mesothelioma, due to exposure to JNJ's talc products when he was a baby. JNJ has denied that its talc contains asbestos,
Insider Monkey15 Best Healthcare Stocks To Buy Now
In this article, we will take a look at the 15 best healthcare stocks to buy now. For more stocks, head on over to 5 Best Healthcare Stocks To Buy Now. In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience. Historically, the demand for healthcare products […]
FortuneFuture Fortune 500 CEOs: 11 up-and-comers that leadership experts see as generational standout bosses
Fortune has identified 11 CEO stars in the making—many of them already in the C-suite, and all potential large-company CEOs.
- Financial Times
Best Of: Inside Johnson & Johnson’s bankruptcy two-step
On May 5th 2020, a couple named Val and Holly Johnson officially make a decision that has been stewing for months. In their lawsuit, they say that Johnson & Johnson sold them talc-based baby powder that had asbestos in it — a known carcinogen.
InvestorPlace7 Undervalued Blue-Chip Stocks to Buy for June 2023
In the wake of the 2022 stock market rout, astute investors should focus on top undervalued blue-chip stocks. All as these sturdy market contenders promise a silver lining with incredible upside potential for the long-term investor. After all, the current market turmoil, spurred by inflation concerns and Federal Reserve rate hikes, is unlikely to persist. Investing in undervalued blue-chip stocks is critical in finding hidden gems that preserve capital and deliver attractive long-term returns. W
Insider MonkeyChatGPT Stock Portfolio: Top 10 Picks
In this article, we will take a look at ChatGPT stock portfolio. To see more such companies, go directly to ChatGPT Stock Portfolio: Top 5 Picks. If there’s one thing that can be learned from literally hundreds of ChatGPT-related posts out there claiming that the AI chatbot has successfully beaten the market, it’s that ChatGPT’s […]
InvestorPlace3 Dow Stocks Poised for a Roaring Relief Rally
It may seem crazy to talk about stocks having a relief rally. But even if you’re the biggest skeptic, you should look at the components of the Dow Jones Industrial Average. Here you’ll find some compelling Dow stocks to buy. I understand there are many reasons to be bearish on this market. The debt ceiling negotiations remain uncomfortably stalemated. The Federal Reserve suggests that higher interest rates will be necessary to combat inflation. And it’s widely believed that the U.S. economy is h
Insider Monkey10 Dementia Medications that are Approved or in Clinical Trials
In this article, we will be taking a look at the 10 dementia medications that are approved or in clinical trials. To skip our detailed analysis, you can go directly to see the 5 dementia medications that are approved or in clinical trials. Advancements in medicine have absolutely changed the way we live right now, […]
Insider Monkey14 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and […]
InvestorPlace7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster
With the debt ceiling issue rating as perhaps the single-most critical issue for the market right now, investors should consider targeting safe-haven stocks for debt default. Naturally, the U.S. government defaulting on its obligations would probably spark a ripple effect. However, it’s also important to consider safe havens because raising the debt ceiling presents its own set of problems. At the time of writing, President Joe Biden and House Speaker Kevin McCarthy are resuming discussions abou
Insider Monkey12 Cheap Dividend Stocks With High Yields
In this article, we discuss 12 cheap dividend stocks with high yields. You can skip our detailed analysis of value stocks and their past performance, and go directly to read 5 Cheap Dividend Stocks With High Yields. The Importance of Investing in Undervalued/Cheap Stocks Investing in value stocks is one of the most popular methods to […]
- InvestorPlace
Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15
The world’s foremost artificial intelligence stock trading algorithm, An-E, predicts that Novavax (NASDAQ:NVAX) stock will gain 7% by June 15. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up… but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month… and JNJ stock fell that exact amount. Wall Street was shocked… but An-E saw it
InvestorPlace7 High-Quality Dow Stocks to Buy on the Dip
If you’re looking to build a portfolio of high-quality blue chip stocks, Dow stocks should be at or near the top of your list. These stocks, aka the components of the Dow Jones Industrial Average (or DJIA), represent 30 of America’s largest, most venerable companies, across multiple sectors. There are a total of 30 Dow components, but instead of buying the whole bunch, you may want to focus on what could be some of the strongest individual opportunities within the index. While few stocks that ma
Insider Monkey10 Best Stocks to Buy According to Billionaire Paul Tudor Jones
In this piece, we will take a look at the ten best stocks to buy according to billionaire Paul Tudor Jones. For more stocks, head on over to 5 Best Stocks to Buy According to Billionaire Paul Tudor Jones. Paul Tudor Jones is one of the richest people in the world. According to Forbes Magazine, […]
- InvestorPlace
3 Reliable Dividend Stocks That Fit in Any Investor’s Portfolio
Growth investors could learn a thing or two from income-oriented investors when it comes to reliable dividend stocks. Not only do these dividend stocks pay a healthy and consistent yield, many of these names trade quite well too. A number of growth stocks are still 40% to 50%, or more, below their all-time highs. At the same time, there are a handful of dividend stocks that are not just hitting 52-week highs, but that are hitting all-time highs despite the difficult market environment. Admittedl
BenzingaJohnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims
As a part of the $8.9 billion effort to settle claims related to talc products, Johnson & Johnson (NYSE: JNJ) has earmarked $400 million to end claims alleging it violated state unfair business practices and consumer protection laws by misleading consumers about the safety of its talc products. J&J subsidiary LTL Management filed a bankruptcy plan in New Jersey late on Monday that details how the company intends to pay different types of cancer victims in a bankruptcy settlement. LTL's new filin
InvestorPlaceDon’t Panic. 3 Defensive Stocks to Diversify Into ASAP
Investors seeking to preserve their capital are increasingly turning to defensive stocks amidst the volatility. These stocks have defensive qualities and the potential to grow dividends, supported by strong free cash flow. While they may not be exciting, defensive stocks have a proven track record of profitability and growth, even in challenging economic conditions. They continuously produce high levels of revenue and cash flow profits, have generally fair price-to-earnings percentages, and offe
InvestorPlaceInvesting for the Long-Term? Here are 7 Must-Have Dividend Stocks
Warren Buffett is credited with saying that his preferred length of time for owning a stock is forever. To give credit where credit is due, the Oracle of Omaha does put his money where his mouth is. Buffett’s holding company, Berkshire Hathaway (NYSE:BRK-A) has several must-have dividend stocks for long-term investing. Buffett has said those stocks will remain in the portfolio until he dies, and maybe after that point. This illustrates a key point about successful dividend investing. You have to
InvestorPlace3 Bargain Dividend Stocks to Boost Your Passive Income
In good times and bad, investors want the best dividend stocks for passive income. However, it’s more than just Googling the top dividend names or biggest yields. In fact, there are a lot of considerations that should go into picking out bargain dividend stocks to boost your passive income. Passive income translates to “hands-off.” While this term is used a lot, it’s often misinterpreted. Meaning many passive-income seekers tend to think it means “no work.” While many sources of passive income a
Insider Monkey25 Best US Cities for People With Allergies
In this article, we will take a look at the 25 best US cities for people with allergies. If you want to see more cities in this selection, go to the 5 Best US Cities for People With Allergies. According to Allied Market Research, the market for allergy treatments was valued at $24.6 billion in […]
BenzingaPromising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment
Protagonist Therapeutics (NASDAQ: PTGX) reported data from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE: JNJ), on Phase 1 and preclinical studies of JNJ-2113 (formerly PN-235). JNJ-2113 is a macrocyclic peptide that binds to the IL-23 receptor with single-digit picomolar affinity and demonstrated potent, selective inhibition of IL-23 signaling in human T cells. Also Read: Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study Although peptid
InvestorPlace7 Overvalued Stocks to Sell for May 2023
While chasing returns and profits is the name of the game for investors, one way to torpedo your portfolio is to fill it with overvalued stocks. Stocks become overvalued when they trade at a higher price than their actual value, based on measurements such as earnings and growth projections. Many investors use price-to-earnings ratios, price-to-sales ratios, or price-to-book ratios to determine if a stock is overvalued, undervalued, or fairly valued. It’s one of the many reasons it pays to review
InvestorPlace9 Hot Stocks to Watch… And Their AI Price Predictions
The world’s foremost artificial intelligence (AI) stock trading algorithm, An-E, has issued price predictions on these nine hot stocks. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up… but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month… and JNJ stock fell that exact amount. Wall Street was shocked… but An-E saw it coming